Recens Medical
South Korean medical device maker developing rapid precision cooling devices for ophthalmic and other surgeries.
Last updated September 29, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Recens Medical Inc. (주식회사 리센스메디컬) is a South Korean medical device manufacturer founded in October 2016 by Kim Gun-ho, a professor of mechanical engineering at UNIST. The company specializes in rapid precision cooling medical devices intended for use in ophthalmic surgery and other applications. Its clinical results have been approved in the United States and Europe. Recens Medical has attracted investment from several Korean venture capital and securities firms, including LB Investment, KB Securities, BNK Investment & Securities, Hyundai Technology Investment, and Lighthouse Combine. In July 2025, the company applied for a preliminary listing review, and in December 2025 it received approval from the Korea Exchange for KOSDAQ listing. It began trading on the KOSDAQ market on March 31, 2026. The company is headquartered in Ulsan, South Korea, where its founder also serves as a professor at UNIST.
History
Recens Medical Inc. was founded on October 31, 2016, by Kim Gun-ho, who holds a Ph.D. in thermoelectric materials from the University of Michigan and became a professor of mechanical engineering at UNIST (Ulsan National Institute of Science and Technology) at the same time. The company was established to develop rapid precision cooling medical devices for ophthalmic surgery and other applications. In 2019, Recens Medical raised 7 billion KRW in Series B funding from investors including LB Investment, KB Securities, BNK Investment & Securities, Hyundai Technology Investment, and Lighthouse Combine. Subsequent investments came from KB Securities, Kiwoom Securities, LB Investment, and STIC Investment. The company's clinical results for its cooling devices were approved in the United States and Europe. On July 2, 2025, Recens Medical applied for a preliminary listing review. In December 2025, it received approval from the Korea Exchange for KOSDAQ listing. The company went public on the KOSDAQ market on March 31, 2026.
Founded by Kim Gun-ho
Raised 7 billion KRW in Series B funding
Applied for preliminary listing review
Received KOSDAQ preliminary approval from Korea Exchange
Listed on KOSDAQ
Products and positioning
Developer of innovative rapid precision cooling medical devices with clinical approvals in the US and Europe.
Rapid precision cooling medical device
A medical device for ophthalmic surgery and other applications, with clinical results approved in the US and Europe.
Sources2 sources
Cite this profile: Cite the canonical profile. /brand-wiki/recens-medical · Editorial policy · How profiles are compiled